SummaryObjective Assessment of treatment routine and out- come for ranolazine in clinical practice as second-line treatment for stable angina pectoris (AP).Design and setting Multicenter, prospective, uncon- trolled, non-interventional study at 88 sites including internal specialists, cardiologists, pneumologists, an- giologists and primary care practices in Austria.